Annual ROE
-222.91%
+144.18%+39.28%
December 31, 2023
Summary
- As of February 7, 2025, PCSA annual return on equity is -222.91%, with the most recent change of +144.18% (+39.28%) on December 31, 2023.
- During the last 3 years, PCSA annual ROE has fallen by -160.08% (-254.78%).
- PCSA annual ROE is now -231.50% below its all-time high of 169.51%, reached on December 31, 2015.
Performance
PCSA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-195.22%
-44.12%-29.20%
September 30, 2024
Summary
- As of February 7, 2025, PCSA quarterly return on equity is -195.22%, with the most recent change of -44.12% (-29.20%) on September 30, 2024.
- Over the past year, PCSA quarterly ROE has dropped by -65.08% (-50.01%).
- PCSA quarterly ROE is now -111.08% below its all-time high of 1761.35%, reached on September 30, 2015.
Performance
PCSA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
PCSA ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +39.3% | -50.0% |
| 3 y3 years | -254.8% | -21.1% |
| 5 y5 years | -474.4% | -21.1% |
PCSA ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -397.1% | +39.3% | -383.8% | +23.8% |
| 5 y | 5-year | -431.9% | +39.3% | -398.6% | +23.8% |
| alltime | all time | -231.5% | +55.2% | -111.1% | +91.5% |
Processa Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -195.22%(+29.2%) |
| Jun 2024 | - | -151.10%(+16.1%) |
| Mar 2024 | - | -130.14%(-8.0%) |
| Dec 2023 | -222.91%(-39.3%) | -141.41%(-44.8%) |
| Sep 2023 | - | -256.08%(+9.8%) |
| Jun 2023 | - | -233.27%(+13.5%) |
| Mar 2023 | - | -205.47%(+27.4%) |
| Dec 2022 | -367.09%(+718.7%) | -161.25%(+97.1%) |
| Sep 2022 | - | -81.80%(+34.8%) |
| Jun 2022 | - | -60.67%(+27.1%) |
| Mar 2022 | - | -47.75%(+18.3%) |
| Dec 2021 | -44.84%(-28.6%) | -40.35%(-37.9%) |
| Sep 2021 | - | -64.95%(-20.0%) |
| Jun 2021 | - | -81.14%(-13.9%) |
| Mar 2021 | - | -94.22%(-30.9%) |
| Dec 2020 | -62.83%(+49.9%) | -136.32%(+71.0%) |
| Sep 2020 | - | -79.71%(+87.3%) |
| Jun 2020 | - | -42.55%(-0.9%) |
| Mar 2020 | - | -42.95%(+9.7%) |
| Dec 2019 | -41.91%(+8.0%) | -39.15%(+10.3%) |
| Sep 2019 | - | -35.48%(+5.5%) |
| Jun 2019 | - | -33.64%(-0.0%) |
| Mar 2019 | - | -33.65%(-13.3%) |
| Dec 2018 | -38.81% | -38.82%(-39.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | -63.66%(-25.5%) |
| Jun 2018 | - | -85.42%(-62.0%) |
| Mar 2018 | - | -224.65%(-238.9%) |
| Dec 2017 | -497.40%(-3580.8%) | 161.76%(+615.1%) |
| Sep 2017 | - | 22.62%(+94.2%) |
| Jun 2017 | - | 11.65%(-3.5%) |
| Mar 2017 | - | 12.07%(-20.1%) |
| Dec 2016 | 14.29%(-91.6%) | 15.11%(-47.1%) |
| Sep 2016 | - | 28.55%(-32.6%) |
| Jun 2016 | - | 42.37%(-73.8%) |
| Mar 2016 | - | 161.65%(-49.2%) |
| Dec 2015 | 169.51%(-153.9%) | 318.27%(-81.9%) |
| Sep 2015 | - | 1761.35%(-176.8%) |
| Jun 2015 | - | -2294.26%(+313.2%) |
| Mar 2015 | - | -555.29%(+8.3%) |
| Dec 2014 | -314.45%(+116.9%) | -512.64%(+50.9%) |
| Sep 2014 | - | -339.77%(+22.5%) |
| Jun 2014 | - | -277.26%(+20.6%) |
| Mar 2014 | - | -229.87%(+40.2%) |
| Dec 2013 | -144.98%(+58.5%) | -164.00%(+15.7%) |
| Sep 2013 | - | -141.73%(+1.2%) |
| Jun 2013 | - | -140.02%(+28.2%) |
| Mar 2013 | - | -109.18%(+25.7%) |
| Dec 2012 | -91.45% | -86.88%(+60.2%) |
| Sep 2012 | - | -54.24% |
FAQ
- What is Processa Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals annual ROE year-on-year change?
- What is Processa Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals quarterly ROE year-on-year change?
What is Processa Pharmaceuticals annual return on equity?
The current annual ROE of PCSA is -222.91%
What is the all time high annual ROE for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high annual return on equity is 169.51%
What is Processa Pharmaceuticals annual ROE year-on-year change?
Over the past year, PCSA annual return on equity has changed by +144.18% (+39.28%)
What is Processa Pharmaceuticals quarterly return on equity?
The current quarterly ROE of PCSA is -195.22%
What is the all time high quarterly ROE for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high quarterly return on equity is 1761.35%
What is Processa Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, PCSA quarterly return on equity has changed by -65.08% (-50.01%)